Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
DNA vaccines showed great promise in preclinical models of infectious and malignant diseases, but their potency was insufficient in clinical trials and is needed to be improved. In this study, we tested systemic administration of two conventional adjuvants, synthetic oligodeoxynucleotide carrying im...
Saved in:
| Main Authors: | Michal Šmahel, Ingrid Poláková, Eva Sobotková, Eva Vajdová |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2011/176759 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA Dissipative System for Controlled Release of Immunostimulatory CpG Oligodeoxynucleotides
by: Aman Ishaqat, et al.
Published: (2024-11-01) -
Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides.
by: Jennifer M Dan, et al.
Published: (2008-04-01) -
A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.
by: Jun-ichi Maeyama, et al.
Published: (2014-01-01) -
The Effect of TLR9 Agonist CpG Oligodeoxynucleotides on the Intestinal Immune Response of Cobia (Rachycentron canadum)
by: Omkar Byadgi, et al.
Published: (2014-01-01) -
Osteogenic CpG Oligodeoxynucleotide, iSN40, Inhibits Osteoclastogenesis in a TLR9-Dependent Manner
by: Rena Ikeda, et al.
Published: (2024-11-01)